Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2004-03-05
2009-06-30
Duffy, Patricia A (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C930S120000
Reexamination Certificate
active
07553930
ABSTRACT:
The invention relates to novel proteins with BAFF dominant negative antagonist, receptor antagonist activity and agonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of BAFF or APRIL-related disorders.
REFERENCES:
patent: 4179337 (1979-12-01), Davis
patent: 4280953 (1981-07-01), Guillemin
patent: 4301144 (1981-11-01), Iwashita
patent: 4496689 (1985-01-01), Mitra
patent: 4640835 (1987-02-01), Shimizu
patent: 4670417 (1987-06-01), Iwasaki
patent: 4791192 (1988-12-01), Nakagawa
patent: 5089261 (1992-02-01), Nitecki
patent: 5183550 (1993-02-01), Mattiessen
patent: 5264209 (1993-11-01), Mikayama
patent: 5383657 (1995-01-01), Rathmell
patent: 5446090 (1995-08-01), Harris
patent: 5506107 (1996-04-01), Cunningham
patent: 5605793 (1997-02-01), Stemmer
patent: 5672662 (1997-09-01), Harris
patent: 5766883 (1998-06-01), Ballance
patent: 5766897 (1998-06-01), Braxton
patent: 5811238 (1998-09-01), Stemmer
patent: 5830721 (1998-11-01), Stemmer
patent: 5833948 (1998-11-01), Tournier
patent: 5837458 (1998-11-01), Minshull
patent: 5876969 (1999-03-01), Fleer
patent: 5900461 (1999-05-01), Harris
patent: 5919455 (1999-07-01), Greenwald
patent: 5932462 (1999-08-01), Harris
patent: 5981200 (1999-11-01), Tsien
patent: 5985236 (1999-11-01), Khan
patent: 5986068 (1999-11-01), Chappel
patent: 5990237 (1999-11-01), Bentley
patent: 6113906 (2000-09-01), Greenwald
patent: 6153265 (2000-11-01), Tomaru
patent: 6188965 (2001-02-01), Mayo et al.
patent: 6214966 (2001-04-01), Harris
patent: 6258351 (2001-07-01), Harris
patent: 6269312 (2001-07-01), Mayo et al.
patent: 6403312 (2002-06-01), Dahiyat
patent: 6413507 (2002-07-01), Bentley
patent: 6437025 (2002-08-01), Harris
patent: 6448369 (2002-09-01), Bentley
patent: 6495659 (2002-12-01), Bentley
patent: 6686196 (2004-02-01), Lieber
patent: 6708120 (2004-03-01), Mayo
patent: 6792356 (2004-09-01), Mayo et al.
patent: 6801861 (2004-10-01), Mayo et al.
patent: 6804611 (2004-10-01), Mayo
patent: 6864359 (2005-03-01), Luo
patent: 6950754 (2005-09-01), Mayo
patent: 7037503 (2006-05-01), Collier
patent: 7056695 (2006-06-01), Dahiyat et al.
patent: 2001/0039480 (2001-11-01), Mayo
patent: 2002/0037286 (2002-03-01), Krause
patent: 2002/0040132 (2002-04-01), Brennand
patent: 2002/0048772 (2002-04-01), Dahiyat et al.
patent: 2002/0061525 (2002-05-01), Yelin et al.
patent: 2002/0110868 (2002-08-01), Dahiyat
patent: 2003/0130827 (2003-07-01), Desjarlais
patent: 2003/0138401 (2003-07-01), Dahiyat
patent: 2003/0166559 (2003-09-01), Desjarlais
patent: 2003/0219864 (2003-11-01), Desjarlais
patent: 2004/0249576 (2004-12-01), Desjarlais
patent: 0 311 589 (1989-04-01), None
patent: 0 400 472 (1990-05-01), None
patent: 0 424 405 (1991-05-01), None
patent: 0786 257 (1997-07-01), None
patent: 0 902 085 (1999-03-01), None
patent: 1 064 951 (2001-01-01), None
patent: 1 098 257 (2001-05-01), None
patent: 0 544 826 (2002-01-01), None
patent: 1 255 826 (2005-09-01), None
patent: WO 87/05330 (1987-09-01), None
patent: WO 99/12965 (1999-03-01), None
patent: WO 99/45026 (1999-09-01), None
patent: WO 99/51632 (1999-10-01), None
patent: WO 00/43032 (2000-07-01), None
patent: WO 00/67034 (2000-11-01), None
patent: WO 01/25277 (2001-04-01), None
patent: WO 01/41812 (2001-06-01), None
patent: WO 01/49830 (2001-07-01), None
patent: WO 01/51510 (2001-07-01), None
patent: WO 01/51629 (2001-07-01), None
patent: WO 01/58493 (2001-08-01), None
patent: WO 02/02597 (2002-01-01), None
patent: WO 02/18445 AS (2002-03-01), None
patent: WO 02/18620 (2002-03-01), None
patent: WO 02/18620 (2002-03-01), None
patent: WO 02/22149 (2002-03-01), None
patent: WO 02/36141 (2002-05-01), None
patent: WO 03/006154 (2003-01-01), None
patent: WO 03/029420 (2003-04-01), None
patent: WO 03/035846 (2003-05-01), None
patent: WO 03/035846 (2003-05-01), None
patent: WO 03/057856 (2003-07-01), None
patent: WO 03/057856 (2003-07-01), None
patent: WO 03/059281 (2003-07-01), None
patent: WO 2004/081043 (2004-09-01), None
patent: WO 2004/081043 (2004-09-01), None
patent: WO 2004/089982 (2004-10-01), None
patent: WO 2005/035570 (2005-04-01), None
Alexandrov, “SARFing the PDB”Protein Eng9(9): 727-32. (1996).
Altschul, et al., “Basic Local Alignment Search Tool,”J. Mol. Biol. 215(3): 403-10 (1990).
Altschul, et al., “Gapped Blast and PSI-Blast: a new generation of protein database search programs,”Nucleic Acids Res. 25: 3389-402 (1997).
Ameloot, P., et al. “Heterotrimers Formed by Tumor Necrosis Factors of Different Species or Muteins”J. Biol. Chem. vol. 276, No. 29 pp. 27098-103(2001).
Anderson, et al., “Human Gene Therapy,”Science256: 808-13 (1992).
Aplin and Wriston, “Preparation, Properties, and Applications of Carbohydrate Conjugates of Proteins and Lipids,”CRC Crit. Rev. Biochem., pp. 259-306 (1981).
Brower, V., “Naked DNA vaccines come of age”Nature Biotechnology, 16: 1304-05 (1998).
Burge and Karlin, “Prediction of Complete Gene Structures In Human Genomic DNA”J Mol Biol268(1): 78-94. (1997).
Chen et al., et al., “Construction and function of two Cys146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator.”J. of Biochem136(1):73-79 (2004).
Creighton, T.E.,Proteins: Structure and Molecular Properties, W.H. Freeman & Co., San Francisco, pp. 79-86 (1983).
Dahiyat, et al., “Automated design of the surface positions of protein helices,”Protein Science6: 1333-37 (1997).
Do, R., and Chen-Kiang, “Mechanism of BlyS action in B cell immunity,”C. Cytokine&Growth Factor Reviews2002, 13: 19-25.
Dzau, et al., “Gene Therapy for Cardiovascular Disease”Trends in Biotechnology11: 205-10 (1993).
Edge, et al., “Deglycosylation of Glycoproteins by Trifluoromethanesulfonic Acid,”Anal. Biochem., 118: 131-37 (1981).
Evan, et al., “Isolation of Monoclonal Antibodies Specific for Human c-mycProto-Oncogene Product,”Molecular and Cellular Biology, 5: 3610-16 (1985).
Field, et al., “Purification of aRAS-Responsive Adenylyl Cyclase Complex fromSaccharomyces cerevisiaeby Use of an Epitope Addition Method,”Mol. Cell. Biol. 8: 2159-65 (1988).
Goldenberg, et al., “Circular and Circularly Permuted Forms of Bovine Pancreatic Trypsin Inhibitor,”J. Mol. Biol. 165: 407-13 (1983).
Groom, J., et al., “Association of BAFF/BlyS overexpression and altered B cell differentiation with Sjögren's syndrome,”The Journal of Clinical Investigation2002, 109: 59-68.
Gross, J., et al., “TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.”Nature2000, 404: 995-99.
Harris, M.E., Pace, N.R., “Analysis of the tertiary structure of bacterial Rnase P RNA”Mol Biol Rep. 1995-96; 22(2-3): 115-23.
Heinemann U., Hahn M., “Circular Permutation of Polypeptide Chains: Implications for Protein Folding and Stability,”Prog. Biophys. molec. Biol. 64(2-3): 121-43 (1995).
Hennecke, et al., “Random Circular Permutation of DsbA Reveals Segments that are Essential for Protein Folding and Stability”,J. Mol. Biol., 286: 1197-215 (1999).
Holm, et al., “Touring protein fold space with Dali/FSSP,”Nucleic Acid Res. 26(1): 316-19 (1998).
Hong, Xia et al., et al., [Reply of Liu, et al. under “Brief Communications”]Nature, 427: 413 (2004).
Hopp, et al., “A Short Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification,”BioTechnology6: 1204-10 (1988).
Kanakaraj, P. et al, “BlyS Binds to B Cells with High Affinity and Induces Activation of the Transcription Factors NF-κB and ELF-1,”.Cytokine, 13, 25-31 (2001).
Karpusas, M., et al., “Cyrstal Structure of Extracellular Human BAFF, a TNF Family member that Sitmulates B Lymphocytes,”J. Mol.Biol., 315, 1145-54 (2002).
Kawasaki, A., et al. “Analysis on the association of human BLYS (BAFF, TNFSF1
Desjarlais John R.
Thomason Adam Read
Zhukovsky Eugene Alexander
Duffy Patricia A
Foster, Esq. David C.
Morgan & Lewis & Bockius, LLP
Silva, Esq. Robin M.
Xencor, Inc.
LandOfFree
BAFF variants and methods thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BAFF variants and methods thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BAFF variants and methods thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4071374